Abiopharma

FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI) Reports the reporting period Financial Results FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $33,000
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: Not disclosed
  • targeting to establish itself as a leading EAI robotics platform company in the United States; and drive the rapid, long-term growth of the U.S. EAI robotics industry. FF began executing this strategy last year, when it accelerated its EAI robotics business; core Phase One capabilities are now complete. 2 The new policies recently announced by the FCC are not intended to cut off global collaboration. Advanced technologies and supply chain capabilities from around the world can still be brought into the United States. For global partners, a compliant U.S. platform can still provide a more efficient path into the U.S. market. This is also where FF offers unique value. FF has already established an evolutionary flywheel driven by its “Four-Core Full-Stack AI” ecosystem, its Global Industry Bridge, and scaled deliveries. Taken together, the new policies are reshaping the rules of the industry and, with full FCC compliance as a prerequisite, further strengthen the value of that bridge—positioning FF to translate its advantages in compliance, global connectivity, and early scaled delivery into market share and a stronger competitive moat. Three-Phase Execution Roadmap for FF EAI Robotics’ “Built in USA” Acceleration Program: In Phase One, by the end of July this year, FF had completed the initial implementation of three core capabilities: the EAI Brain, Industry Productivity Solutions and Developer Platform, and the EAI Data Factory. This laid the technical foundation for the continued development of its EAI Devices. On the manufacturing side, FF also began establishing its U.S. footprint, including evaluating a retrofit of the Company’s Hanford factory and possible sites for a new facility. In Phase Two, from this August through the first quarter of 2027